Debra L Allison

Title: Debra L. Allison: Innovator in Pharmaceutical Chemistry

Introduction

Debra L. Allison is a prominent inventor based in Scotch Plains, NJ (US), known for her significant contributions to pharmaceutical chemistry. With a total of seven patents to her name, she has made remarkable advancements in the field of medicinal compounds.

Latest Patents

Among her latest patents is the development of N-alkenyl-3-hydroxybenzo[b]thiophene-2-carboxamide derivatives, which serve as dual-action treatments for various medical conditions. This innovative method aims to increase resistance to gastrointestinal irritation while addressing pain, fever, inflammation, arthritic conditions, asthma, allergic disorders, skin diseases, cardiovascular disorders, psoriasis, inflammatory bowel disease, glaucoma, and other diseases mediated by prostaglandins and leukotrienes. Another notable patent involves aryl-substituted thiophene 3-ols and their derivatives, which act as 5-lipoxygenase inhibitors, proving useful in treating inflammation and other leukotriene-mediated diseases.

Career Highlights

Debra L. Allison is currently associated with Merck & Company, Inc., where she continues to push the boundaries of pharmaceutical research. Her work has not only contributed to the development of new therapeutic agents but has also enhanced the understanding of complex biochemical interactions.

Collaborations

Throughout her career, Debra has collaborated with esteemed colleagues, including Bruce E. Witzel and Allan N. Tischler. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Debra L. Allison's contributions to pharmaceutical chemistry exemplify the impact of innovative thinking in medicine. Her patents reflect a commitment to improving health outcomes through scientific research and development.